Your browser doesn't support javascript.
loading
Development and multicenter validation of FIB-6: A novel, machine learning, simple bedside score to rule out liver cirrhosis and compensated advanced chronic liver disease in patients with chronic hepatitis C.
Shiha, Gamal; Soliman, Reham; Mikhail, Nabiel N H; Alswat, Khalid; Abdo, Ayman; Sanai, Faisal; Derbala, Moutaz F; Örmeci, Necati; Dalekos, George N; Al-Busafi, Said; Hamoudi, Waseem; Sharara, Ala I; Zaky, Samy; El-Raey, Fathiya; Mabrouk, Mai; Marzouk, Samir; Toyoda, Hidenori.
Afiliación
  • Shiha G; Gastroenterology and Hepatology Department, Egyptian Liver Research Institute and Hospital (ELRIAH), Sherbin, Egypt.
  • Soliman R; Hepatology and Gastroenterology Unit, Internal Medicine Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt.
  • Mikhail NNH; Gastroenterology and Hepatology Department, Egyptian Liver Research Institute and Hospital (ELRIAH), Sherbin, Egypt.
  • Alswat K; Tropical Medicine Department, Faculty of Medicine, Port Said University, Port Fuad, Egypt.
  • Abdo A; Gastroenterology and Hepatology Department, Egyptian Liver Research Institute and Hospital (ELRIAH), Sherbin, Egypt.
  • Sanai F; Biostatistics and Cancer Epidemiology Department, South Egypt Cancer Institute, Assiut University, Asyut, Egypt.
  • Derbala MF; Department of Medicine, Liver Disease Research Center, College of Medicine, King Saud University, Riyadh, Kingdom of Saudi Arabia.
  • Örmeci N; Department of Medicine, Liver Disease Research Center, College of Medicine, King Saud University, Riyadh, Kingdom of Saudi Arabia.
  • Dalekos GN; Gastroenterology Unit, Department of Medicine, King Abdulaziz Medical City, Jeddah, Saudi Arabia.
  • Al-Busafi S; Gastroenterology and Hepatology Department, Hamad Hospital, Doha, Qatar.
  • Hamoudi W; Department of Gastroenterology, Ankara University School of Medicine, Ankara, Turkey.
  • Sharara AI; Department of Medicine and Research Laboratory of Internal Medicine, National Expertise Center of Greece in Autoimmune Liver Diseases, General University Hospital of Larissa, Larissa, Greece.
  • Zaky S; Department of Medicine, Division of Gastroenterology and Hepatology, College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Oman.
  • El-Raey F; Internal Medicine Department, Al-Bashir Hospital, Amman, Jordan.
  • Mabrouk M; Division of Gastroenterology, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
  • Marzouk S; Department of Hepatogastroenterology and Infectious Diseases, Al-Azhar University, Cairo, Egypt.
  • Toyoda H; Department of Hepatogastroenterology and Infectious Diseases, Al-Azhar University, Damietta, Egypt.
Hepatol Res ; 52(2): 165-175, 2022 Feb.
Article en En | MEDLINE | ID: mdl-34767312

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies Aspecto: Patient_preference Idioma: En Revista: Hepatol Res Año: 2022 Tipo del documento: Article País de afiliación: Egipto Pais de publicación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies Aspecto: Patient_preference Idioma: En Revista: Hepatol Res Año: 2022 Tipo del documento: Article País de afiliación: Egipto Pais de publicación: Países Bajos